Virtual Medicinal Product (VMP) - Sirolimus 2mg/g gel
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Sirolimus 2mg/g gel | Start Date 01-10-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Cutaneous
- Form
- Cutaneous gel
- Ontology Form/Route
- gel.cutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- n/a
- BNF Codes
-
- BNF code 08020200
| Code | Start Date | End Date |
|---|---|---|
| 42307211000001107 | 01-10-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Sirolimus | Based on Ingredient Substance | 2 mg | 1 gram |
Name
Sirolimus
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMSirolimus
-
VMP(Current) Sirolimus 2mg/g gel
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 10 gram | 34000 | Part VIIIA Category C |